Association of Overweight and Inflammatory Indicators with Breast Cancer: A Cross-Sectional Study in Chinese Women
DOI: https://doi.org/10.2147/ijwh.s428696
2024-05-06
International Journal of Women s Health
Abstract:Juan-Min Zha, 1, &ast Mei Zhang, 1, &ast Tao Wang, 2, &ast Hua-Shan Li, 1, 2, &ast Quan-Yao Ban, 1, &ast Mei Liu, 1 Xue-Xue Jiang, 1 Shi-Ying Guo, 2 Jing Wang, 2 Ya-Ru Zhou, 2 Yu-Hong Liu, 2 Wei-Qi He, 1, 2 Hong Xu 1 1 Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, People's Republic of China; 2 Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cambridge-Suda (CAM-SU) Genomic Resource Center, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wei-Qi He; Hong Xu, Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, People's Republic of China, Tel +86-512-6588-3545, Email ; Objective: This cross-sectional study aimed to explore the association of overweight and inflammatory indicators with breast cancer risk in Chinese patients. Methods: Weight, height, and peripheral blood inflammatory indicators, including white blood cell count (WBC), neutrophil count (NE), lymphocyte count (LY), platelet count (PLT) and the concentration of hypersensitivity C-reactive protein (hsCRP), were collected in 383 patients with benign breast lumps (non-cancer) and 358 patients with malignant breast tumors (cancer) at the First Affiliated Hospital of Soochow University, China, from March 2018 to July 2020. Body mass index (BMI), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) were determined according to the ratio equation. The correlations among overweight, inflammatory indicators, and the proportion of non-cancer or cancer cases were analyzed. Results: BMI is associated with an increased breast cancer risk. Compared with non-cancer patients, the average WBC count, NE count, NLR, and level of hsCRP were significantly higher in cancer patients. The level of hsCRP was closely associated with the size of malignant breast tumors. Conclusion: We conclude that overweight and high levels of hsCRP may serve as putative risk factors for malignant breast tumors in Chinese women. Keywords: breast cancer, body mass index, overweight, chronic inflammation, inflammatory indicator Breast cancer is the most prevalent invasive cancer in women and the leading cause of cancer-related deaths in women around the world. 1–3 In China, breast cancer is also the most common cancer in women. In 2022, breast cancer will be China's fourth leading cause of death in women. 4 Therefore, it is of great significance to determine the putative-risk factors for breast cancer. Numerous studies aimed at enhancing the survival rate and prognosis of breast cancer patients have been reported. For instance, a novel approach has been developed to identify subtype-specific network biomarkers for predicting breast cancer survivability, achieving remarkable classification performance, and demonstrating potential clinical utility for personalized treatment strategies. 5 Moreover, an innovative method that combines high-dimensional embedding and residual neural networks has been introduced to accurately classify breast cancer Nottingham Prognostic Index (NPI) classes while identifying crucial prognostic biomarkers. 6 It is well known that obesity has a huge impact on human health. The proportion of obese people who suffer from metabolic diseases such as diabetes, hypertension, hyperlipidemia and sleep apnea syndrome is significantly higher than that of nonobese people. 7 In recent years, many studies have shown that obesity is related to the occurrence of malignant tumors such as colorectal cancer, pancreatic cancer, bladder cancer and endometrial cancer. 8–14 Meanwhile, an increasing number of studies have revealed that obesity plays a significant role in promoting the onset and development of malignant tumors, poor prognosis, and drug resistance to anticancer therapy. 15,16 The production of insulin and insulin-like growth factors, adipocytokines, the inflammatory response, hypoxia, and oxidative stress are potential risk factors for obesity-related cancers. 17–23 Obesity is linked to an increased incidence of breast cancer, a poor prognosis, an increased chance of disease recurrence, and increased mortality in postmenopausal women. 24–26 Comparing to non-obese patients, obese breast cancer patients exhibit significantly poorer overall survival rates. Additionally, obese breast cancer -Abstract Truncated-
obstetrics & gynecology